热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Purified anti-mouse CD3 Antibody
产品名称：
Purified anti-mouse CD3 Antibody
产品类别：
抗体
产品编号：
100201
产品应用：
100201
[价格]
规格 价格 库存
50µg ￥ 360 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per million cells in 100 ?l volume.?For immunohistochemistry on frozen tissue sections, a concentration of 10 ?g/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  2. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  2. Abdel-Gadir A, et al. 2019. Nat Med. 25:1164. PubMed
  3. Hamada T, et al. 2008. J Immunol. 180:1843. PubMed
  4. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  5. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  6. Kulkarni NN, et al. 2020. J Invest Dermatol. 140:645. PubMed
  7. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  8. Xiao J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:386. PubMed
  9. Bergstrom K, et al. 2008. Infect Immun. 76:796. PubMed
  10. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  11. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  12. Hawse WF, et al. 2019. J Immunol. 203:2771. PubMed
  13. Zhao J, et al. 2021. JCI Insight. 6:. PubMed
  14. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  15. Xu L, et al. 2017. Int J Biol Macromol. . 10.1016/j.ijbiomac.2017.07.090. PubMed
  16. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  17. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  18. Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
  19. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  20. Rasoulouniriana D, et al. 2019. J Clin Invest. 129:4151. PubMed
  21. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  22. Haque M, et al. 2021. Viruses. 13:. PubMed
  23. Wabitsch S, et al. 2021. STAR Protoc. 2:100517. PubMed
  24. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  25. Kerdidani D, et al. 2019. Nat Commun. 10:1405. PubMed
  26. Hayashi Y, et al. 2017. J Cancer. 8:2478. PubMed
  27. Düsedau HP, et al. 2019. Glia. 67:193. PubMed
  28. Liu T, et al. 2020. Sci Adv. 6:eaay1497. PubMed
  29. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  30. Boothby IC, et al. 2021. Nature. 599:667. PubMed
  31. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  32. Chen Y, et al. 2018. Oncoimmunology. 7:e1388484. PubMed
  33. Child KM et al. 2018. The Journal of Neuroscience. 38(31):6806-6824 . PubMed
  34. Recino A, et al. 2019. Gene Ther. 26:40. PubMed
  35. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  36. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  37. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  38. Adamson SE, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1020. PubMed
  39. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  40. Yoshihara T, et al. 2020. Gut Microbes. 11:1385. PubMed
  41. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  42. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  43. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  44. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  45. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  46. Forsyth KS, et al. 2020. PLoS Pathog. 16:e1008685. PubMed
  47. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  48. Kopec A, et al. 2014. Toxicol Sci. 141:515. PubMed
  49. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  50. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  51. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  52. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  53. Miret JJ, et al. 2019. J Immunother Cancer. 7:32. PubMed
  54. Bittner-Eddy PD, et al. 2020. Front Immunol. 11:677. PubMed
  55. Dooley K, et al. 2021. Mol Ther. 29:1729. PubMed
  56. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  57. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  58. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  59. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  60. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  61. You X, et al. 2022. Front Genet. 12:790990. PubMed
  62. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  63. Clark K, et al. 2019. Front Immunol. 10:2355. PubMed
  64. Gilfillan CB, et al. 2020. Eur J Immunol. 50:505. PubMed
  65. Fitzpatrick E, et al. 2017. PLoS One. 10.1371/journal.pone.0169273. PubMed
  66. Karhadkar TR, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 318:L165. PubMed
  67. Sugita S, et al. 2017. Arthritis Res Ther. 19:176. PubMed
  68. Patterson AR, et al. 2019. J Allergy Clin Immunol. 143:245. PubMed
  69. Williams SK, et al. 2018. Sci Rep. 8:13628. PubMed
  70. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  71. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  72. Morgado P, et al. 2011. Infect Immun. 79:4401. PubMed
  73. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  74. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  75. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  76. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  77. Flietner E, et al. 2022. Sci Rep. 12:10616. PubMed
  78. Pan S, et al. 2021. Front Cell Dev Biol. 9:629306. PubMed
  79. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  80. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  81. von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed
  82. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  83. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  84. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  85. Tilley S, et al. 2007. J Immunol . 178:3208. PubMed
  86. Kang LJ, et al. 2020. Sci Rep. 10:5603. PubMed
  87. Liu J, et al. 2022. Stem Cell Res Ther. 13:247. PubMed
  88. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  89. Di Dalmazi G, et al. 2019. J Immunol. 202:1350. PubMed
  90. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  91. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  92. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
  93. He Y, et al. 2021. eLife. 10:00. PubMed
  94. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  95. Katsuyama T, et al. 2019. J Clin Invest. 129:5411. PubMed
  96. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  97. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  98. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  99. Gonzales C, et al. 2016. PLoS One. 11:e0164557. PubMed
  100. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  101. Rastelli D, et al. 2021. J Clin Invest. :e150789. PubMed
  102. Moretti FA, et al. 2021. Sci Rep. 11:23221. PubMed
  103. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  104. Robles-Valero J, et al. 2021. EMBO J. 40:e108125. PubMed
  105. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  106. Yadav A, et al. 2009. Am J Physiol Renal Physiol. 298:734. PubMed
  107. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  108. Ega?a–Gorro?o L, et al. 2019. Atherosclerosis. 289:184. PubMed
  109. Regan–Komito D, et al. 2017. Front Immunol. 1.459027778. PubMed
  110. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  111. K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
RRID
AB_312658 (BioLegend Cat. No. 100201) AB_312659 (BioLegend Cat. No. 100202)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线